Supply Chain

Intas Pharma Appoints Amit Modi as Associate VP of Supply Chain Management

Intas Pharmaceuticals, a formidable entity in the healthcare industry, has announced a significant addition to its leadership team. On May 28, 2025, the company appointed Amit Modi as the Associate Vice President of Supply Chain Management. This strategic move underscores Intas Pharma's commitment to bolstering its supply chain operations, a critical component in the pharmaceutical sector.

The Strategic Appointment

The announcement of Amit Modi's appointment was made through a LinkedIn post by Intas Pharmaceuticals, signaling its intent to leverage Modi's extensive experience to enhance the company’s supply chain management. With over 23 years of global experience in the pharmaceutical industry, Modi is set to oversee the intricate logistics that ensure the timely and efficient delivery of medicines and healthcare products.

Supply chain management remains a backbone in the pharmaceutical business, directly impacting the availability and accessibility of essential medicines. Intas Pharma's decision to appoint an experienced leader like Modi reflects the company's proactive approach in addressing the complexities of global supply chains.

Amit Modi’s Professional Journey

Amit Modi brings a wealth of experience to Intas Pharma, having previously dedicated over 15 years at Torrent Pharma. His professional expertise spans several critical areas, including:

  • Demand forecasting
  • Production and supply planning
  • Long-term capacity planning
  • Logistics
  • Third-party logistics (3PL) management
  • Customer service

These competencies are essential for navigating the challenges faced by pharmaceutical companies in the dynamic global market. Modi’s leadership is anticipated to usher in enhanced efficiencies and capabilities within Intas Pharma’s supply chain operations.

Intas Pharma: A Global Presence

Intas Pharmaceuticals has established itself as a vertically integrated global powerhouse in pharmaceutical formulation development, manufacturing, and marketing. The firm operates in more than 85 countries worldwide, with subsidiaries under the Accord Healthcare name facilitating its international reach.

Intas has consistently expanded its product portfolio and operations, achieving growth through both organic means and strategic acquisitions. This growth trajectory is further complemented by its investment in high-barrier developments such as biosimilars and new chemical entities, positioning the company at the forefront of the pharmaceutical innovation landscape.

"The appointment of Amit Modi as Associate Vice President of Supply Chain Management is a testament to Intas Pharma's dedication to excellence in delivering healthcare solutions globally," an industry analyst noted.

Looking Ahead

As Amit Modi steps into his role at Intas Pharma, the industry will be watching closely to see how his leadership influences the company's supply chain strategies and operations. His appointment marks a pivotal moment for Intas, promising advancements in the efficiency and effectiveness of its supply chain processes.

With a solid foundation and a clear vision for the future, Intas Pharmaceuticals is poised to continue its trajectory of growth and innovation, ensuring the delivery of high-quality healthcare products to markets around the world.

In conclusion, the strategic appointment of Amit Modi signals Intas Pharma's ongoing commitment to enhancing its operations and staying ahead in the competitive pharmaceutical landscape. As the company continues to forge new paths in the industry, Modi's expertise will undoubtedly play a crucial role in shaping the future of Intas Pharma’s supply chain management.